These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15735413)

  • 1. Rhinosporidiosis: what is the cause?
    Arseculeratne SN
    Curr Opin Infect Dis; 2005 Apr; 18(2):113-8. PubMed ID: 15735413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The assessment of the viability of the endospores of Rhinosporidium seeberi with MTT (3-[4, 5-dimethyl-2-thiazolyl]-2, 5-diphenyl-2H-tetrazolium bromide).
    Arseculeratne SN; Atapattu DN
    Mycol Res; 2004 Dec; 108(Pt 12):1423-30. PubMed ID: 15757178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of biocides (antiseptics and disinfectants) on the endospores of Rhinosporidium seeberi.
    Arseculeratne SN; Atapattu DN; Balasooriya P; Fernando R
    Indian J Med Microbiol; 2006 Apr; 24(2):85-91. PubMed ID: 16687856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human anti-rhinosporidial antibody does not cause metabolic inactivation or morphological damage in endospores of Rhinosporidium seeberi, in vitro.
    Arseculeratne SN; Atapattu DN; Eriyagama NB
    Indian J Med Microbiol; 2005 Jan; 23(1):14-9. PubMed ID: 15928415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nature and significance of the electron-dense bodies of the endospores of rhinosporidium seeberi: their reactions with MTT (3-[4,5-dimethyl-2-thiazolyl]-2,5-diphenyl-2H-tetrazolium bromide) and TMRE (tetramethyl-rhodamine ethyl ester).
    Arseculeratne SN; Atapattu DN; Wickramaratne K
    Med Mycol; 2005 May; 43(3):261-73. PubMed ID: 16010853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of the endospores and sporangia of Rhinosporidium seeberi on Percoll columns.
    Atapattu DN; Arseculeratne SN; Rajapakse RP; Perera NA; Eriyagama NB
    Mycopathologia; 1999; 145(3):113-9. PubMed ID: 10685445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-rhinosporidial antibody levels in patients with rhinosporidiosis and in asymptomatic persons, in Sri Lanka.
    Arseculeratne SN; Kumarasiri PV; Rajapakse RP; Perera NA; Arseculeratne G; Atapattu DN
    Mycopathologia; 2004 Aug; 158(2):157-64. PubMed ID: 15518343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in rhinosporidiosis and Rhinosporidium seeberi.
    Arseculeratne SN
    Indian J Med Microbiol; 2002; 20(3):119-31. PubMed ID: 17657050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro studies on the mechanisms of endospore release by Rhinosporidium seeberi.
    Mendoza L; Herr RA; Arseculeratne SN; Ajello L
    Mycopathologia; 1999; 148(1):9-15. PubMed ID: 11086480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immune responses (CMIR) to Rhinosporidium seeberi in mice.
    Jayasekera S; Arseculeratne SN; Atapattu DN; Kumarasiri R; Tilakaratne WM
    Mycopathologia; 2001; 152(2):69-79. PubMed ID: 11761147
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Töz S
    Turkiye Parazitol Derg; 2020 Dec; 44(4):258-260. PubMed ID: 33269573
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated immune responses (CMIR) in human rhinosporidiosis.
    de Silva NR; Huegel H; Atapattu DN; Arseculeratne SN; Kumarasiri R; Gunawardena S; Balasooriya P; Fernando R
    Mycopathologia; 2001; 152(2):59-68. PubMed ID: 11761146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to infect congenitally immunodeficient SCID and NUDE mice with Rhinosporidium seeberi.
    Arseculeratne SN; Hussein FN; Atapattu DN; Pathmanathan R
    Med Mycol; 2000 Oct; 38(5):393-5. PubMed ID: 11092388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report: Rhinosporidiosis Literature Review.
    Arias AF; Romero SD; Garcés CG
    Am J Trop Med Hyg; 2020 Dec; 104(2):708-711. PubMed ID: 33289469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunolocalization of an endogenous antigenic material of Rhinosporidium seeberi expressed only during mature sporangial development.
    Herr RA; Mendoza L; Arseculeratne SN; Ajello L
    FEMS Immunol Med Microbiol; 1999 Mar; 23(3):205-12. PubMed ID: 10219592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elusive treatment for human rhinosporidiosis.
    Janardhanan J; Patole S; Varghese L; Rupa V; Tirkey AJ; Varghese GM
    Int J Infect Dis; 2016 Jul; 48():3-4. PubMed ID: 27109109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular evidence for multiple host-specific strains in the genus Rhinosporidium.
    Silva V; Pereira CN; Ajello L; Mendoza L
    J Clin Microbiol; 2005 Apr; 43(4):1865-8. PubMed ID: 15815010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhinosporidium seeberi: a human pathogen from a novel group of aquatic protistan parasites.
    Fredricks DN; Jolley JA; Lepp PW; Kosek JC; Relman DA
    Emerg Infect Dis; 2000; 6(3):273-82. PubMed ID: 10827117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhinosporidiosis: a description of an unprecedented outbreak in captive swans (Cygnus spp.) and a proposal for revision of the ontogenic nomenclature of Rhinosporidium seeberi.
    Kennedy FA; Buggage RR; Ajello L
    J Med Vet Mycol; 1995; 33(3):157-65. PubMed ID: 7666295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regional sero-epidemiology of rhinosporidiosis in Sri Lankan humans and animals.
    Sudasinghe T; Rajapakse RP; Perera NA; Kumarasiri PV; Eriyagama NB; Arseculeratne SN
    Acta Trop; 2011; 120(1-2):72-81. PubMed ID: 21801708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.